These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1677201)

  • 1. Anatomical localization of the binding and functional characterization of responses to dopexamine hydrochloride in the rat mesenteric vasculature.
    Amenta F; Ricci A; Napoleone P; Vyas SJ; Lokhandwala MF
    Pharmacology; 1991; 42(4):211-22. PubMed ID: 1677201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical, autoradiographic and pharmacological evidence for the involvement of tubular DA-1 receptors in the natriuretic response to dopexamine hydrochloride.
    Vyas SJ; Apparsundaram S; Ricci A; Amenta F; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):21-30. PubMed ID: 1674360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopexamine hydrochloride in the human heart: receptor binding and effects on cAMP generation.
    Napoleone P; Ricci A; Ferrante F; Amenta F
    Eur Heart J; 1992 Dec; 13(12):1709-17. PubMed ID: 1363232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dopexamine: a new dopaminergic agonist].
    Perrin G; Papazian L; Martin C
    Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effects of dopamine hydrochloride and dopexamine hydrochloride on abdominal and femoral hemodynamics in anesthetized dogs.
    van Kesteren RG; Heethaar RM; Charbon GA; Heethaar J; Brouwer FA
    Circ Shock; 1993 Jul; 40(3):227-33. PubMed ID: 8348685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog.
    Smith GW; Hall JC; Farmer JB; Simpson WT
    J Pharm Pharmacol; 1987 Aug; 39(8):636-41. PubMed ID: 2888855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cultured mesenteric vascular smooth muscle cells express dopamine DA1-receptors.
    Balmforth AJ; Lyall F; Morton JI; Ball SG
    Eur J Pharmacol; 1988 Oct; 155(3):305-8. PubMed ID: 2853067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopexamine hydrochloride in the human kidney: localization, receptor binding and effect on 3'-5'-cyclic adenosine monophosphate generation.
    Napoleone P; Cavallotti C; Ricci A; Amenta F
    Nephron; 1993; 65(3):385-91. PubMed ID: 7904730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IP66 (1[2-ethoxy-2-(3'-pyridyl)ethyl]-4-(2'-methoxy-phenyl)piperazine) enhances beta-adrenoceptor-induced vasodilatation in rat mesenteric vascular bed.
    Perretti F; Nediani C; Manzini S
    Arch Int Pharmacodyn Ther; 1990; 306():87-99. PubMed ID: 1963768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting effects of dopexamine hydrochloride on electrolyte excretion in canine kidney.
    Bass AS
    J Pharmacol Exp Ther; 1990 May; 253(2):798-802. PubMed ID: 1971021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effects of dopexamine, a novel DA1 receptor and beta 2-adrenoceptor agonist, on cardiac function and splanchnic circulation in a canine model of hemorrhagic shock.
    Chintala MS; Moore RJ; Lokhandwala MF; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):296-300. PubMed ID: 8097568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
    Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic effects of dopexamine hydrochloride in the canine kidney.
    Bass AS
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):33-6. PubMed ID: 1347154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of dopexamine on the cardiovascular system of the dog.
    Brown RA; Farmer JB; Hall JC; Humphries RG; O'Connor SE; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):609-19. PubMed ID: 4027482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of arterial lesions induced by dopaminergic compounds in the rat.
    Kerns WD; Arena E; Macia RA; Bugelski PJ; Matthews WD; Morgan DG
    Toxicol Pathol; 1989; 17(1 Pt 2):203-13. PubMed ID: 2568682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.
    Böhm M; Pieske B; Schnabel P; Schwinger R; Kemkes B; Klövekorn WP; Erdmann E
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):549-59. PubMed ID: 2478768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal vasodilatation by dopexamine and fenoldopam due to alpha 1-adrenoceptor blockade.
    Martin SW; Broadley KJ
    Br J Pharmacol; 1995 May; 115(2):349-55. PubMed ID: 7670737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the pharmacological interventions to prevent oxygen free radical (OFR)-mediated toxicity; effects of dopexamine, a DA1 receptor and beta 2 adrenoceptor agonist.
    Jacinto SM; Lokhandwala MF; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):277-83. PubMed ID: 7824044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative significance of dopamine receptors, beta adrenoceptors and norepinephrine uptake inhibition in the cardiovascular actions of dopexamine hydrochloride.
    Goldberg LI; Bass AS
    Am J Cardiol; 1988 Aug; 62(5):37C-40C. PubMed ID: 2841837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopexamine hydrochloride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute cardiac insufficiency.
    Fitton A; Benfield P
    Drugs; 1990 Feb; 39(2):308-30. PubMed ID: 1970288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.